You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆汇港股聚焦(7.01)︱恒大半年销售及回款创历史同期纪录 雅生活服务H股全流通获中证监批准
格隆汇 07-01 23:48

【AH股】

君实生物(01877.HK):科创板定价55.50元/股

中州证券(01375.HK):非公开发行新A股申请获中证监核准批覆

【停复牌】

年年卡(03773.HK)预期中期盈利不少于1500万元 2日复牌

凯华集团(00275.HK)延迟刊发2020年年报 继续停牌

【运营数据】

中国恒大(03333.HK):6月合约销售额升51.3%至760.5亿元 上半年销售及回款刷新历史同期纪录

碧桂园(02007.HK)6月权益合同销售额达561.1亿元

【财务数据】

受累投资物业公平值亏损 森信纸业集团(00731.HK)年度盈利降58.4%

汇能集团(01539.HK)年度业绩由盈转亏至1.1亿港元

新昌创展控股(01781.HK)年度净亏2.97亿港元 核数师不发表意见

久康国际(00850.HK)年度净亏收窄70.9%至1.17亿港元

中国再生医学(08158.HK)年度净亏收窄66.9%至3.95亿港元

汛和集团(01591.HK)年度净亏扩大31.5%至3305.3万港元

中国支付通(08325.HK)年度净亏扩大130.3%至7.10亿港元 核数师出具非标意见

【重大事项】

华领医药宣布Dorzagliatin与二甲双胍联合用药III期注册临床研究24周核心研究取得正面结果

雅生活服务(03319.HK):H股全流通及增发境外上市外资股申请获中证监批准

思捷环球(00330.HK):有意未来三个月执行重组计划内的重组措施

维亚生物(01873.HK):3.92亿元成功竞投浦东新区工厦物业

【并购出售】

中国心连心化肥(01866.HK)完成收购瑞诚科技51%股权

中国心连心化肥(01866.HK):央企扶贫基金2亿元投资河南心连心化学落实

宏华集团(00196.HK):3.1亿元出售2套6000HP电动压裂泵及附属配套设备

丽珠医药(01513.HK):完成出售尼科公司19.99%股权 预计增加净利润8523.99万元

【分红付息】

建设银行(00939.HK)2019年度A股派息每10股3.2元 股权登记日7月9日

【人事变动】

华兴资本控股(01911.HK)委任丛林为集团总裁

前桥水联席CEO梅爱苓出任汇丰控股(00005.HK)独董

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account